{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:53:39Z","timestamp":1789829619039,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["YG2023LC13"],"award-info":[{"award-number":["YG2023LC13"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04746-z","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:47:15Z","timestamp":1760928435000},"page":"4427-4440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatobiliary disorders associated with triazole antifungal agents: a disproportionality and Bayesian analysis based on the FAERS database"],"prefix":"10.1007","volume":"399","author":[{"given":"Ruogu","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Sui Zi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"4746_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/cpt.3378","volume":"116","author":"K Abouir","year":"2024","unstructured":"Abouir K, Exquis N, Gloor Y, Daali Y, Samer CF (2024) Phenoconversion due to drug-drug interactions in CYP2C19 genotyped healthy volunteers. Clin Pharmacol Ther 116:1121\u20131129","journal-title":"Clin Pharmacol Ther"},{"key":"4746_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1179\/acb.2001.055","volume":"56","author":"B Adriaenssens","year":"2001","unstructured":"Adriaenssens B, Roskams T, Steger P, Van Steenbergen W (2001) Hepatotoxicity related to itraconazole: report of three cases. Acta Clin Belg 56:364\u2013369","journal-title":"Acta Clin Belg"},{"key":"4746_CR3","doi-asserted-by":"publisher","first-page":"e0123021","DOI":"10.1128\/JCM.01230-21","volume":"59","author":"H Badali","year":"2021","unstructured":"Badali H, Ca\u00f1ete-Gibas C, McCarthy D, Patterson H, Sanders C, David MP, Mele J, Fan H, Wiederhold NP (2021) Epidemiology and antifungal susceptibilities of Mucoralean fungi in clinical samples from the United States. J Clin Microbiol 59:e0123021","journal-title":"J Clin Microbiol"},{"key":"4746_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14113688","author":"V Bazojoo","year":"2025","unstructured":"Bazojoo V et al (2025) Effects of pregnancy on liver and kidney cyst growth rates in autosomal dominant polycystic kidney disease: a pilot study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14113688","journal-title":"J Clin Med"},{"key":"4746_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/17425255.2023.2203860","volume":"19","author":"M Biswas","year":"2023","unstructured":"Biswas M, Shobana J, Jinda P, Sukasem C (2023) Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine. Expert Opin Drug Metab Toxicol 19:165\u2013174","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4746_CR6","doi-asserted-by":"crossref","unstructured":"Cadena J, Thompson GR, 3rd, Patterson TF (2021) Aspergillosis: epidemiology, diagnosis, and treatment. Infect Dis Clin North Am 35:415\u2013434","DOI":"10.1016\/j.idc.2021.03.008"},{"key":"4746_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.15585\/mmwr.mm7219a4","volume":"72","author":"AS Caplan","year":"2023","unstructured":"Caplan AS et al (2023) Notes from the field: first reported U.S. cases of tinea caused by Trichophyton indotineae - New York City, December 2021-March 2023. MMWR Morb Mortal Wkly Rep 72:536\u2013537","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4746_CR8","doi-asserted-by":"publisher","unstructured":"C\u00e1rdenas Parra LY, Rojas Rodriguez AE, P\u00e9rez C\u00e1rdenas JE, P\u00e9rez-Agudelo JM (2024) Molecular evaluation of the mRNA expression of the ERG11, ERG3, CgCDR1, and CgSNQ2 genes linked to fluconazole resistance in Candida glabrata in a Colombian population. J Fungi. https:\/\/doi.org\/10.3390\/jof10070509","DOI":"10.3390\/jof10070509"},{"key":"4746_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/20420986221143266","volume":"13","author":"S Chai","year":"2022","unstructured":"Chai S, Zhan JL, Zhao LM, Liu XD (2022) Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS. Ther Adv Drug Saf 13:20420986221143266","journal-title":"Ther Adv Drug Saf"},{"key":"4746_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1255918","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Xu S, Yu W, Sun C, Zhang W (2024) Evaluating cardiac disorders associated with triazole antifungal agents based on the US food and drug administration adverse event reporting system database. Front Pharmacol 15:1255918","journal-title":"Front Pharmacol"},{"key":"4746_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab296","volume":"8","author":"JH Cheng","year":"2021","unstructured":"Cheng JH, Yip CW, Jiang YK, Zhou LH, Que CX, Luo Y, Wang X, Zhao HZ, Zhu LP (2021) Clinical predictors impacting cryptococcal dissemination and poor outcome in patients with cirrhosis. Open Forum Infect Dis 8:ofab296","journal-title":"Open Forum Infect Dis"},{"key":"4746_CR12","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.2147\/DDDT.S475706","volume":"18","author":"L Cheng","year":"2024","unstructured":"Cheng L, You X, Wang X, Yu M, Jia C (2024) The role of plasma trough concentration of voriconazole and voriconazole N-oxide in its hepatotoxicity in adult patients. Drug Des Devel Ther 18:3617\u20133628","journal-title":"Drug Des Devel Ther"},{"key":"4746_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293453","volume":"18","author":"DGD Christofaro","year":"2023","unstructured":"Christofaro DGD, Ritti-Dias RM, Tebar WR, Werneck AO, Bittencourt MS, Cucato GG, Santos RD (2023) Are C-reactive protein concentrations affected by smoking status and physical activity levels? A longitudinal study. PLoS ONE 18:e0293453","journal-title":"PLoS ONE"},{"key":"4746_CR14","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","volume":"25","author":"OA Cornely","year":"2025","unstructured":"Cornely OA et al (2025) Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis 25:e280\u2013e293","journal-title":"Lancet Infect Dis"},{"key":"4746_CR15","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW (2024) Global incidence and mortality of severe fungal disease. Lancet Infect Dis 24:e428\u2013e438","journal-title":"Lancet Infect Dis"},{"key":"4746_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03476-5","volume":"11","author":"CC Derella","year":"2021","unstructured":"Derella CC, Tingen MS, Blanks A, Sojourner SJ, Tucker MA, Thomas J, Harris RA (2021) Smoking cessation reduces systemic inflammation and circulating endothelin-1. Sci Rep 11:24122","journal-title":"Sci Rep"},{"key":"4746_CR17","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i2.103325","volume":"17","author":"A Giorgio","year":"2025","unstructured":"Giorgio A, CIRAC\u00ec E, De Luca M, Stella G, Giorgio V (2025) Hepatic abscess and hydatid liver cyst: European infectious disease point of view. World J Hepatol 17:103325","journal-title":"World J Hepatol"},{"issue":"15","key":"4746_CR18","doi-asserted-by":"publisher","first-page":"12462","DOI":"10.3390\/ijms241512462","volume":"24","author":"S Granata","year":"2023","unstructured":"Granata S, Canistro D, Vivarelli F, Morosini C, Rullo L, Mercatante D, Rodriguez-Estrada MT, Baracca A, Sgarbi G, Solaini G, Ghini S, Fagiolino I, Sangiorgi S, Paolini M (2023) Potential harm of IQOS smoke to rat liver. Int J Mol Sci. 24(15):12462. https:\/\/doi.org\/10.3390\/ijms241512462","journal-title":"Int J Mol Sci."},{"key":"4746_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105413","author":"N Hirun","year":"2024","unstructured":"Hirun N, Mahadlek J, Limmatvapirat S, Sriamornsak P, Yonemochi E, Furuishi T, Kraisit P (2024) Fabrication and characterization of pectin films containing solid lipid nanoparticles for buccal delivery of fluconazole. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25105413","journal-title":"Int J Mol Sci"},{"key":"4746_CR20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/17425255.2023.2292112","volume":"19","author":"Y Huang","year":"2023","unstructured":"Huang Y, Jia Y, Chen X, Wang C, Wang Y, Wang M, Wu P, Shen J (2023) CYP3A inhibitor itraconazole affect pharmacokinetic behavior of famitinib and its active metabolite: results of a single-center, single-arm, open-label and fixed sequence study. Expert Opin Drug Metab Toxicol 19:1005\u20131013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4746_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13883","volume":"17","author":"C Huynh","year":"2024","unstructured":"Huynh C, Dingemanse J, Meyer Zu Schwabedissen HE, Fonseca M, Sidharta PN (2024) The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3\/CXCR7 antagonist, ACT-1004-1239. Clin Transl Sci 17:e13883","journal-title":"Clin Transl Sci"},{"key":"4746_CR22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1001\/jamadermatol.2022.3745","volume":"158","author":"A Khurana","year":"2022","unstructured":"Khurana A, Agarwal A, Agrawal D, Panesar S, Ghadlinge M, Sardana K, Sethia K, Malhotra S, Chauhan A, Mehta N (2022) Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis\/cruris: a randomized clinical trial. JAMA Dermatol 158:1269\u20131278","journal-title":"JAMA Dermatol"},{"key":"4746_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.730826","volume":"12","author":"S Li","year":"2021","unstructured":"Li S, Wu S, Gong W, Cao P, Chen X, Liu W, Xiang L, Wang Y, Huang J (2021) Application of population pharmacokinetic analysis to characterize CYP2C19 mediated metabolic mechanism of voriconazole and support dose optimization. Front Pharmacol 12:730826","journal-title":"Front Pharmacol"},{"key":"4746_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-27687-0","volume":"13","author":"H Li","year":"2023","unstructured":"Li H, Zhang M, Jiao X, Zhu Y, Liu Y, Zeng L, Wang H, Zhang L, Zhang W, Zhang L (2023) Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA adverse event reporting system database. Sci Rep 13:4475","journal-title":"Sci Rep"},{"key":"4746_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1455721","volume":"15","author":"J Ling","year":"2024","unstructured":"Ling J, Yang X, Dong L, Jiang Y, Zou S, Hu N (2024) Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis. Front Pharmacol 15:1455721","journal-title":"Front Pharmacol"},{"key":"4746_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01913-0","volume":"25","author":"WH Liu","year":"2024","unstructured":"Liu WH, Hu HM, Li C, Shi Q, Liu CH, Liu AX, Li YF, Zhang Y, Mao P, Fan BF (2024) Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. food and drug administration (FDA) adverse event reporting system (FAERS) database. J Headache Pain 25:206","journal-title":"J Headache Pain"},{"key":"4746_CR27","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1097\/JS9.0000000000002194","volume":"111","author":"H Liu","year":"2025","unstructured":"Liu H, Yang Q, Li Z, Yan S, Ming S (2025) Systematic analysis of sugammadex-related adverse drug reaction signals using FAERS database. Int J Surg 111:1988\u20131994","journal-title":"Int J Surg"},{"key":"4746_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","volume":"397","author":"JA Maertens","year":"2021","unstructured":"Maertens JA et al (2021) Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet 397:499\u2013509","journal-title":"Lancet"},{"key":"4746_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12010054","author":"I Marincu","year":"2021","unstructured":"Marincu I (2021) Clinical profile of 24 AIDS patients with cryptococcal meningitis in the HAART era: a report from an infectious diseases tertiary hospital in Western Romania. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics12010054","journal-title":"Diagnostics"},{"key":"4746_CR30","doi-asserted-by":"crossref","unstructured":"Navarro-Mendoza MI, P\u00e9rez-Arques C, Parker J, Xu Z, Kelly S, Heitman J (2024) Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the Mucor species complex. mBio 15:e0166124","DOI":"10.1128\/mbio.01661-24"},{"key":"4746_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122058","volume":"336","author":"A Nemmar","year":"2024","unstructured":"Nemmar A, Beegam S, Yuvaraju P, Zaaba NE, Elzaki O, Yasin J, Adeghate E (2024) Pathophysiologic effects of waterpipe (shisha) smoke inhalation on liver morphology and function in mice. Life Sci 336:122058","journal-title":"Life Sci"},{"key":"4746_CR32","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/cid\/ciab841","volume":"74","author":"P Nyirjesy","year":"2022","unstructured":"Nyirjesy P, Schwebke JR, Angulo DA, Harriott IA, Azie NE, Sobel JD (2022) Phase 2 randomized study of oral ibrexafungerp versus fluconazole in vulvovaginal candidiasis. Clin Infect Dis 74:2129\u20132135","journal-title":"Clin Infect Dis"},{"key":"4746_CR33","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/jac\/dkad143","volume":"78","author":"J Stemler","year":"2023","unstructured":"Stemler J et al (2023) Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). J Antimicrob Chemother 78:1813\u20131826","journal-title":"J Antimicrob Chemother"},{"key":"4746_CR34","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1124\/dmd.124.001608","volume":"52","author":"S Subash","year":"2024","unstructured":"Subash S, Prasad B (2024) Age-dependent changes in cytochrome P450 abundance and composition in human liver. Drug Metab Dispos 52:1363\u20131372","journal-title":"Drug Metab Dispos"},{"key":"4746_CR35","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1111\/j.1572-0241.1999.01623.x","volume":"94","author":"JA Talwalkar","year":"1999","unstructured":"Talwalkar JA, Soetikno RE, Carr-Locke DL, Berg CL (1999) Severe cholestasis related to intraconazole for the treatment of onychomycosis. Am J Gastroenterol 94:3632\u20133633","journal-title":"Am J Gastroenterol"},{"key":"4746_CR36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00207-21","volume":"65","author":"X Tian","year":"2021","unstructured":"Tian X, Zhang C, Qin Z, Wang D, Yang J, Zhang X (2021) Impact of CYP2C19 phenotype and drug-drug interactions on voriconazole concentration in pediatric patients. Antimicrob Agents Chemother 65:e0020721","journal-title":"Antimicrob Agents Chemother"},{"key":"4746_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1462510","volume":"16","author":"Y Tian","year":"2025","unstructured":"Tian Y, Jin M, Ning H (2025) A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database. Front Pharmacol 16:1462510","journal-title":"Front Pharmacol"},{"key":"4746_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae330","volume":"17","author":"J Waiser","year":"2024","unstructured":"Waiser J et al (2024) Kidney transplantation in patients with polycystic kidney disease: increased risk of infection does not compromise graft and patient survival. Clin Kidney J 17:sfae330","journal-title":"Clin Kidney J"},{"key":"4746_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jcph.2357","volume":"64","author":"J Wang","year":"2024","unstructured":"Wang J, Shen Y, Wu Z, Ge W (2024) Population pharmacokinetics of voriconazole and dose optimization in elderly Chinese patients. J Clin Pharmacol 64:253\u2013263","journal-title":"J Clin Pharmacol"},{"key":"4746_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","volume":"18","author":"X Wu","year":"2023","unstructured":"Wu X (2023) Recent advances in understanding of pathogenesis of alcohol-associated liver disease. Annu Rev Pathol 18:411\u2013438","journal-title":"Annu Rev Pathol"},{"key":"4746_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79512-x","volume":"14","author":"YL Yang","year":"2024","unstructured":"Yang YL, Yi QY, Han Y, Li Y, Yang R (2024) The effectiveness and safety of posaconazole enteric-coated tablet versus oral suspension in invasive fungal infections. Sci Rep 14:27887","journal-title":"Sci Rep"},{"key":"4746_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1124\/dmd.109.029769","volume":"38","author":"SB Yanni","year":"2010","unstructured":"Yanni SB, Annaert PP, Augustijns P, Ibrahim JG, Benjamin DK Jr., Thakker DR (2010) In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3. Drug Metab Dispos 38:25\u201331","journal-title":"Drug Metab Dispos"},{"key":"4746_CR43","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1080\/14740338.2024.2391492","volume":"23","author":"J Yun","year":"2024","unstructured":"Yun J, Wang Z, Liu W (2024) Voriconazole-induced central nervous system toxicity: a pharmacovigilance study based on FDA adverse event reporting system (FAERS) database. Expert Opin Drug Saf 23:1309\u20131316","journal-title":"Expert Opin Drug Saf"},{"key":"4746_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijid.2013.11.017","volume":"20","author":"YH Zhong","year":"2014","unstructured":"Zhong YH, Tan F, Li M, Liu J, Wang X, Yuan Y, Zhong XF, Peng FH (2014) Comparisons of presentations and outcomes of cryptococcal meningitis between patients with and without hepatitis B virus infection. Int J Infect Dis 20:31\u201336","journal-title":"Int J Infect Dis"},{"key":"4746_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1039867","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Wei Z, Xu B, Liu M, Xu R, Wu X (2022) Pharmacovigilance of triazole antifungal agents: analysis of the FDA adverse event reporting system (FAERS) database. Front Pharmacol 13:1039867","journal-title":"Front Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04746-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04746-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04746-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:59:07Z","timestamp":1772006347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04746-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4746"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04746-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}